5Stevens LA, Levey AS. Chronic kidney disease in the elderly-How to assess risk[J]. The New England Journal of Medicine, 2005,352:21- 22.
6Stevens LA, Zhang YP, Schmid CH, et al. Evaluating the performance of equations for estimating glomerular filtration rate[J]. Journal of Nephrology, 2008,21 (6) : 797-807.
8Uhlmann EJ, Hock KG, Lssitt C, et al. Reference.Intervals for plasma eystatin C in healthy volunteers and renal patients, as measured by the Dade Behring BN II system, and correlation with creatinine[J]. Clin Chem, 2001,47(11) :2 031-2 033.
9Randers E, Erlandsen EJ, Pedersen OL, et al. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function[J]. Clin Nephrol, 2000,54(3):203- 209.
10Tomino Y, Suzuki S, Gohda T, et al. Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy[J]. Clin Lab Anal,2001,15(1):25-29.
2Svensson M, Gorst 一 Rasmussen A,Schmidt EB, et al. NT - Pro -BNP is an independent Predictor of mortality in Patients with end -stage renal disease [J] . Clin NePhrol, 2009 ,71(4) :380 — 386.
